Evidence map›Paper›PMID 31892136›Full record

ArticleInternational journal of molecular sciences2019

Haplotype in

Marco Antonio Ponce-Gallegos, Gloria Pérez-Rubio, Adriana García-Carmona, Jesús García-Gómez, Rafael Hernández-Zenteno, Alejandra Ramírez-Venegas, Ramcés Falfán-Valencia

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. An association study ofBiochemistry and biophysics reports · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Heterozygous Genotype rs17580 AT (PiS) inInternational journal of chronic obstructive pulmonary disease · 2020
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marco Antonio Ponce-GallegosHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.ORCID 0000-0003-4992-9913
Gloria Pérez-RubioHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Adriana García-CarmonaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Jesús García-GómezHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Rafael Hernández-ZentenoTobacco Smoking and COPD Research Department, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Alejandra Ramírez-VenegasTobacco Smoking and COPD Research Department, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Ramcés Falfán-ValenciaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City 14080, Mexico.
Instituto Nacional de Enfermedades Respiratorias · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protease inhibitor S (PiS) and protease inhibitor Z (PiZ) variants in the

Indexed as

AdultAgedAged, 80 and overAllelesalpha 1-AntitrypsinCase-Control StudiesFemaleForced Expiratory VolumeGene FrequencyGenetic Predisposition to DiseaseGenotypeHaplotypesHumansLungMaleMexicoalpha 1-AntitrypsinSERPINA1 protein, humanbiomass burningCOPDPiSPiZSERPINA1SNPstobacco smoking

Identifiers

PMID31892136
PMCPMC6982076
OpenAlexW2996875015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.